Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Not yet recruiting 2Completed 2Unknown 1Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 38Pancreatic Neoplasms 11Esophageal Neoplasms 8Biliary Tract Neoplasms 8Colorectal Neoplasms 7Neoplasm Metastasis 3Gastrointestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumors 3Neoplasms 2Head and Neck Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Advanced Non-Small Cell Lung Cancer 2Advanced Gastric Cancer 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Progression Free Survival 1Patients With Advanced or Metastatic Solid Tumors 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Overall Survival 1Nasopharyngeal Carcinoma 1Hand-Foot Syndrome 1Carcinoma, Transitional Cell 1Breast Neoplasms 1Advanced Pancreatic Cancer 1Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 39Cisplatin 24Oxaliplatin 15pembrolizumab 12Capecitabine 12Fluorouracil 9Leucovorin 7Albumin-Bound Paclitaxel 7lenvatinib 6Radiofrequency Ablation 6Panitumumab 6130-nm albumin-bound paclitaxel 6Irinotecan 5Bevacizumab 5durvalumab 4Taxes 4Nivolumab 4Hepatectomy 4Drug Therapy 4tremelimumab 3apatinib 3Radiosurgery 3Platinum 3Injections 3Floxuridine 3Cetuximab 31,2-diaminocyclohexaneplatinum II citrate 3trametinib 2spartalizumab 2sintilimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Cholangiocarcinoma × S 1 (combination) × Clear all
NCT02592538 2019-11-19

Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma

First People's Hospital of Hangzhou

Phase NA Completed
66 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT01963325 2018-02-05

S-1 in Combination With Abraxane in Treating Cholangiocarcinoma

Sun Yat-sen University

Phase 2 Completed
50 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡